PL380070A1 - Methods and compositions for the oral administration of prodrugs of proton pump inhibitors - Google Patents

Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Info

Publication number
PL380070A1
PL380070A1 PL380070A PL38007004A PL380070A1 PL 380070 A1 PL380070 A1 PL 380070A1 PL 380070 A PL380070 A PL 380070A PL 38007004 A PL38007004 A PL 38007004A PL 380070 A1 PL380070 A1 PL 380070A1
Authority
PL
Poland
Prior art keywords
prodrugs
compositions
methods
oral administration
proton pump
Prior art date
Application number
PL380070A
Other languages
Polish (pl)
Inventor
Jie Shen
Devin F. Welty
Diane D. Tang-Liu
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Priority to PL380070A priority Critical patent/PL380070A1/en
Publication of PL380070A1 publication Critical patent/PL380070A1/en

Links

PL380070A 2004-10-01 2004-10-01 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors PL380070A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL380070A PL380070A1 (en) 2004-10-01 2004-10-01 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380070A PL380070A1 (en) 2004-10-01 2004-10-01 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Publications (1)

Publication Number Publication Date
PL380070A1 true PL380070A1 (en) 2006-12-27

Family

ID=40561710

Family Applications (1)

Application Number Title Priority Date Filing Date
PL380070A PL380070A1 (en) 2004-10-01 2004-10-01 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Country Status (1)

Country Link
PL (1) PL380070A1 (en)

Similar Documents

Publication Publication Date Title
EP1715853A4 (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
HK1119951A1 (en) Methods and compositions for oral administration of proteins
EP1799865A4 (en) Methods for the administration of iloperidone
EP2068841A4 (en) Novel formulations of proton pump inhibitors and methods of using these formulations
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
EP2015632A4 (en) Stable hydroalcoholic oral spray formulations and methods
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL182686A0 (en) New modified release tablet formulations for proton pump inhibitors
IL217713A0 (en) Compounds and compositions for delivering active agents
EP1757273A4 (en) Preparation for oral administration
IL183256A0 (en) Therapeutic compositions for intranasal administration of ketorolac
IL177402A0 (en) Composition for oral administration of tamsulosin hydrochloride
IL180907A0 (en) Risedronate compositions and their methods of use
EP1763358A4 (en) Appetite-suppressing compositions and methods
EP1745004B8 (en) Aryl ketone compounds and compositions for delivering active agents
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL183986A0 (en) Pharmaceutical compounds and compositions
HK1113308A1 (en) Pharmaceutical formulations of gallium salts
HK1142823A1 (en) Formulations for the oral administration of therapeutic agents and related methods
EP1720563A4 (en) Methods and compositions for the treatment of inflammation
EP2099416A4 (en) Anti-calculus dental composition and methods for using same
GB0413366D0 (en) Binder-free photopolymerizable compositions
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
IL186337A0 (en) Stannsoporfin compositions and administration
PT2474528E (en) Antineoplasic compounds and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)